0001140361-18-014819.txt : 20180323
0001140361-18-014819.hdr.sgml : 20180323
20180323165651
ACCESSION NUMBER: 0001140361-18-014819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180322
FILED AS OF DATE: 20180323
DATE AS OF CHANGE: 20180323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIVIS GREG J
CENTRAL INDEX KEY: 0001410677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 18710787
MAIL ADDRESS:
STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
doc1.xml
FORM 4
X0306
4
2018-03-22
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001410677
DIVIS GREG J
C/O AVADEL PHARMACEUTICALS PLC
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
DUBLIN
L2
15
IRELAND
0
1
0
0
See Remarks
ADSs
33100
D
Stock Option (right to buy)
10.40
2026-12-14
ADSs
150000
150000
D
Stock Option (right to buy)
8.95
2027-12-12
ADSs
100000
100000
D
Stock Option (right to buy)
7.06
2018-03-22
4
A
0
50000
7.06
A
2028-03-22
ADSs
50000
50000
D
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
Includes 22,500 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 15,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 7,500 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant).
Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 3/22/2018 grant date.
Executive VP, Chief Operating Officer
/s/ Phillandas T. Thompson as attorney in fact for Greg J. Divis
2018-03-23